1. Home
  2. KTTA vs AQB Comparison

KTTA vs AQB Comparison

Compare KTTA & AQB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KTTA
  • AQB
  • Stock Information
  • Founded
  • KTTA 2020
  • AQB 1991
  • Country
  • KTTA United States
  • AQB United States
  • Employees
  • KTTA N/A
  • AQB N/A
  • Industry
  • KTTA Biotechnology: Pharmaceutical Preparations
  • AQB
  • Sector
  • KTTA Health Care
  • AQB
  • Exchange
  • KTTA Nasdaq
  • AQB Nasdaq
  • Market Cap
  • KTTA 2.8M
  • AQB 2.9M
  • IPO Year
  • KTTA 2021
  • AQB N/A
  • Fundamental
  • Price
  • KTTA $0.89
  • AQB $0.79
  • Analyst Decision
  • KTTA
  • AQB
  • Analyst Count
  • KTTA 0
  • AQB 0
  • Target Price
  • KTTA N/A
  • AQB N/A
  • AVG Volume (30 Days)
  • KTTA 2.3M
  • AQB 152.9K
  • Earning Date
  • KTTA 05-15-2025
  • AQB 08-05-2025
  • Dividend Yield
  • KTTA N/A
  • AQB N/A
  • EPS Growth
  • KTTA N/A
  • AQB N/A
  • EPS
  • KTTA N/A
  • AQB N/A
  • Revenue
  • KTTA N/A
  • AQB N/A
  • Revenue This Year
  • KTTA N/A
  • AQB N/A
  • Revenue Next Year
  • KTTA N/A
  • AQB N/A
  • P/E Ratio
  • KTTA N/A
  • AQB N/A
  • Revenue Growth
  • KTTA N/A
  • AQB N/A
  • 52 Week Low
  • KTTA $0.79
  • AQB $0.47
  • 52 Week High
  • KTTA $7.50
  • AQB $1.94
  • Technical
  • Relative Strength Index (RSI)
  • KTTA 38.94
  • AQB 50.51
  • Support Level
  • KTTA $0.87
  • AQB $0.78
  • Resistance Level
  • KTTA $0.95
  • AQB $0.95
  • Average True Range (ATR)
  • KTTA 0.07
  • AQB 0.08
  • MACD
  • KTTA 0.01
  • AQB -0.01
  • Stochastic Oscillator
  • KTTA 40.41
  • AQB 22.11

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).

About AQB AquaBounty Technologies Inc.

AquaBounty Technologies Inc is engaged in the field of land-based aquaculture and the use of technology to improve the productivity and sustainability. The company's objective is to ensure the availability of high-quality seafood to meet consumer demand while addressing critical production constraints in the popular farmed species.

Share on Social Networks: